Supernus Pharmaceuticals
SUPN
#5129
Rank
โ‚ฌ1.57 B
Marketcap
27,07ย โ‚ฌ
Share price
1.78%
Change (1 day)
-30.42%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2026 (TTM): -โ‚ฌ31.53 Million

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.86 Billion. In 2025 the company made an earning of -โ‚ฌ38.46 Million a decrease over its 2024 earnings that were of โ‚ฌ73.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ31.53 Million-18.04%
2025 -โ‚ฌ38.46 Million-152.66%
2024 โ‚ฌ73.02 M1446.62%
2023 โ‚ฌ4.72 M-92.36%
2022 โ‚ฌ61.76 M-29.8%
2021 โ‚ฌ87.98 M-49.79%
2020 โ‚ฌ0.17 B12.99%
2019 โ‚ฌ0.15 B7.58%
2018 โ‚ฌ0.14 B54.9%
2017 โ‚ฌ93.07 M84.25%
2016 โ‚ฌ50.51 M202.27%
2015 โ‚ฌ16.71 M-462.04%
2014 -โ‚ฌ4.62 Million-94%
2013 -โ‚ฌ76.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.05 B-51,828.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.57 B-20,044.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.66 B-96,171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.32 B-31,411.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
-โ‚ฌ0.2 Billion 485.87%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ1.38 B-4,299.11%๐Ÿ‡บ๐Ÿ‡ธ USA